戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 urements are used for glaucoma diagnosis and patient monitoring.
2  (TM) is easier to perform and allows easier patient monitoring.
3 g, assuming appropriate device selection and patient monitoring.
4 quipment that had to be reused on uncohorted patients; monitoring adherence to infection control prec
5 -effective and is a recommended strategy for patient monitoring, although further empirical evidence
6       Wired technology can be cumbersome for patient monitoring and can restrict the behavior of the
7  analysis of CTC shows promise for real-time patient monitoring and clinical outcome prediction in th
8 view of current wireless technology used for patient monitoring and disease management.
9            Adverse events were recorded, and patient monitoring and laboratory assay were performed a
10 IV testing, ART delivery and adherence, good patient monitoring and support, and data to monitor prog
11 reduce the risk of first recurrence in NMBIC patients, monitoring and preserving their renal function
12 ists, preoperative and sedative medications, patient monitoring, and airway endoscopic techniques, as
13 value in terms of risk assessment, continued patient monitoring, and for therapeutic decision-making.
14 roved algorithms for identifying RV failure, patient monitoring, and weaning protocols for both isola
15  fluid resuscitation, early antibiotics, and patient monitoring, are relatively inexpensive.
16 r use of one assay platform for longitudinal patient monitoring, but the data also reinforce the noti
17 rdized TM SMWT is feasible and allows easier patient monitoring, but there is a statistically signifi
18  spent 70%, 3%, 3%, and 24% of their time on patient monitoring, collaboration, system maintenance, a
19 ase, may make these agents ideal for staging patients, monitoring disease pretherapy or posttherapy,
20 I 12-lead ECGs, providing a means to enhance patient monitoring during MR imaging and MR-guided inter
21 mens, utility of the electroencephalogram in patient monitoring, emerging drug therapies and patient
22         This highlights the need for careful patient monitoring in all immunosuppressive settings at
23 ch directions and methods that could improve patient monitoring in clinical practice.
24  clues for preclinical safety assessment and patient monitoring in trials of stem cell therapies.
25                                              Patient monitoring includes time adapted HR, SO(2), ECG,
26 ular assays to improve disease diagnosis and patient monitoring is a critical need.
27 tation, early antibiotic administration, and patient monitoring is limited by lack of supplies and sk
28 ensitive, information-rich assays that allow patient monitoring of immune responses, tumor regression
29                                     Reliable patient monitoring of viral loads requires the detection
30 th patient care (appropriate prescribing and patient monitoring), patient behavior (adherence), and c
31 are highly relevant for such applications as patient monitoring, proper use of therapeutic guidelines
32                                       Remote patient monitoring represents a paradigm shift in the wa
33    Current guidelines recommend using remote patient monitoring (RPM) for implantable cardioverter-de
34 lantable defibrillators (ICD), use of remote patient monitoring (RPM) is associated with lower risk o
35 ed the association between the use of remote patient monitoring (RPM) of implantable cardioverter def
36 sessed the cost-effectiveness of alternative patient monitoring strategies.
37 he design of remote telemetry work and other patient monitoring tasks in critical and intermediate ca
38         Two standards were used in measuring patient monitoring: the Health Plan Employer Data and In
39 farction, from diagnosis and misdiagnosis to patients' monitoring, treatment, and potential complicat
40 nitiate therapy, choice of initial regimens, patient monitoring, when to change therapy, and how best
41 , selection of appropriate initial regimens, patient monitoring, when to change therapy, and what reg

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。